1 January 2023 in Revista da Associação Médica Brasileira
In patients who experience difficulties in oral feeding, alimentary intake can be supported by creating direct access into the stomach through a percutaneous endoscopic gastrostomy. The present study purposed to compare naïve and exchanged percutaneous endoscopic gastrostomy tubes in terms of Helicobacter pylori infection and other clinical characteristics. A total of 96 cases who underwent naïve or exchanged percutaneous endoscopic gastrostomy procedures with various indications were incorporated into the study. The patients' demographic data, such as age and gender, etiology of percutaneous endoscopic gastrostomy, anti-HBs status, Helicobacter pylori status, the presence of atrophy and intestinal metaplasia, biochemical parameters, and lipid profiles, had been analyzed. In addition, the anti-HCV and anti-HIV statuses had also been evaluated. The most common indication for percutaneous endoscopic gastrostomy placement was dementia in 26 (27.08%) cases (p=0.033). The presence of Helicobacter pylori positivity was significantly lower in the exchange group compared to the naïve group (p=0.022). Total protein, albumin, and lymphocyte levels were significantly higher in the exchange group compared to the naïve group (both p=0.001), and the mean calcium, hemoglobin, and hematocrit levels were statistically significantly higher in the exchange group (p<0.001). Preliminary outcomes of the present study revealed that enteral nutrition attenuates the incidence of Helicobacter pylori infection. Considering the acute-phase reactant, the significantly lower ferritin values in the exchange group suggest that there is no active inflammatory process in the patients and that immunity is sufficient.
8 July 2022 in Medical Science and Discovery
Objective: Excessive salt consumption could play a role for developing gastric cancer as well as Helicobacter pylori (HP) infection. However, there is no report about the connection between serum sodium levels and HP infection. This study aimed to investigate the relationship between serum sodium disorders and HP infection. Material and Methods: In this single-center, retrospective, descriptive study, we evaluated the presence of HP infection by enzyme-linked immunosorbent assay (ELISA) among patient with serum sodium disturbances. Patients were divided into two groups as to their serum sodium levels (hypernatremia: Sodium level above 145 mmol/l, and hyponatremia: Sodium level below 135 mmol/l). Results: In total, 54 patients, half of them were hypernatremic (27), included in the study. At total, 15 (55.6%) patients tested positive for HP immunoglobulin G (Ig G) by ELISA method in hyponatremic patients, 17 (63%) patients tested positive for HP Ig G in hypernatremic patients. There was no difference between groups in terms of HP Ig G seropositivity (p=0.58). Other hand, 9 (33%) patients tested positive for HP Ig A among hyponatremic patients, 19 (70%) patients tested positive for HP Ig A in hypernatremic patients (p=0.029). Conclusion: According to our results, Hypernatremic patients have high risk for HP infection. Other hand, the presence of HP infection could be a driven-factor in the development of hypernatremia among elderly patients. Larger-scale studies are needed to reveal the relationship between hypernatremia and gastroenteritis.
31 August 2026 in Medical Journal of Western Black Sea
Aim: Cyclin-dependent kinase (CDK) 4/6 inhibitors combined with endocrine therapy are recommended as the first-line treatment for hormone receptor-positive, HER2-negative metastatic breast cancer without visceral crisis. However, CDK4/6 inhibitor efficacy has been reported to differ between HER2-low and HER2-zero tumors; emerging data suggest that the therapeutic efficacy of CDK4/6 inhibitors may be reduced in HER2-low breast cancer. Therefore, we aimed to evaluate this association in a cohort of patients treated with CDK4/6 inhibitors.Material and Methods: In this single-center retrospective study, 121 patients with hormone receptor-positive, HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors between January 2019 and March 2025 were evaluated. Cases were classified as HER2-low or HER2-zero. Progression-free survival (PFS) and overall survival (OS) were assessed using the Kaplan-Meier method.Results: Among 121 hormone receptor-positive, HER2-negative metastatic breast cancer patients treated with CDK4/6 inhibitors, 53.7% were in the HER2-zero group and 46.3% in the HER2-low group. The median follow-up duration was 28.6 months (range: 5.1-56.4 months) and the median age was 62 years (range: 33-89 years). Ribociclib was used in 68.6% and palbociclib in 31.4% of these cases. The incidence of grade 3-4 toxicities was comparable between the groups (p=0.948). There was no statistically significant difference in median PFS (31.1 vs 34.8 months, p=0.314) or OS (42.3 vs 39.9 months, p=0.946) between the HER2-zero and HER2-low groups. Ribociclib and palbociclib demonstrated similar survival outcomes across HER2 subgroups. Conclusion: The clinical significance of HER2 status in patients treated with CDK4/6 inhibitors remains unclear. In our cohort, we were unable to demonstrate an association between HER2 status and PFS or OS among patients receiving CDK4/6 inhibitor therapy.
8 October 2024 in Uludağ Üniversitesi Tıp Fakültesi Dergisi
"En sağlıklı yiyecekler" veya "süper gıdalar" listelerindeki sebzeler arasında yer alan Brassica Oleracea var. acephala (Karalahana) bitkisi, özellikle Karadeniz Bölgesi’nde sıklıkla tüketilmektedir. Bu çalışmada Doğu Karadeniz Bölgesi’nde gastroskopi ile değerlendirilmiş olan hastalarda karalahana ve kırmızı et tüketiminin mide histopatolojisi ve kan laboratuvar parametreleri üzerine olan etkisinin saptanması amaçlandı. Bu kesitsel araştırma 1 Mart 2022 – 30 Nisan 2022 tarihleri arasında Giresun Üniversitesi Eğitim ve Araştırma Hastanesi Gastroenteroloji Polikliniği’ne başvuran gastroskopi yapılmış ve mide biyopsisi alınmış olguların sonuçlarının retrospektif olarak değerlendirilmesi ile gerçekleştirilmiştir. Hastalar telefonla aranarak aylık karalahana ve kırmızı et tüketim sıklıkları sorulmuştur. Olguların % 60,1’i kadındı ve ortalama yaş 55,44 ± 14,34’tü. Hastaların bir ayda, karalahana tükettiği gün sayısı medyan 4 [0 - 30] gün, kırmızı et tükettiği gün sayısı ise medyan 2 [0 - 20] gündü. Erkek hastaların gastrik biyopsilerinde Helicobacter pylori (H. pylori) pozitifliği kadınlara göre anlamlı derecede fazlaydı (sırasıyla % 50,8 ve % 32,7; p = 0,021). Karalahana ve kırmızı et tüketimi ile hastaların gastrik biyopsilerinde H. pylori, intestinal metaplazi ve atrofi varlığı arasında istatistiksel olarak anlamlı bir ilişki saptanmadı. Hastaların yaşı arttıkça kırmızı et tüketimlerinin anlamlı derecede azaldığı belirlendi (p=0,014). Hastaların aylık kırmızı et tüketimi arttıkça serum kalsiyum düzeyinin de anlamlı derecede arttığı belirlendi (p=0,025). Sonuç olarak karalahana ve kırmızı et tüketim sıklığı ile mide biyopsisinde H. pylori pozitifliği, atrofi ve intestinal metaplazi saptanma sıklığı arasında anlamlı bir ilişki bulunmazken, bu konuda yapılacak daha kapsamlı ve prospektif çalışmalarla daha net sonuçlar ortaya konulabilir.